NIH: mRNA vaccine generates immune response in older adults

by on

NIH: mRNA vaccine generates immune response in older adults
tjordan_drupal
Sep 30, 2020

An experimental mRNA vaccine for the COVID-19 virus generated a strong immune response in older adults in a phase 1 clinical trial, who generally tolerated it well, the National Institutes of Health reports.

The National Institute of Allergy and Infectious Diseases developed the vaccine with Moderna Inc.

The phase 1 trial began in March and later added 40 healthy adults over age 55, who received two doses and will be followed for a year to monitor the long-term effects of the vaccine. According to the researchers, the results support testing the vaccine in older adults in an ongoing large Phase 3 trial.

Headline

NIH: mRNA vaccine generates immune response in older adults
tjordan_drupal
Sep 30, 2020

An experimental mRNA vaccine for the COVID-19 virus generated a strong immune response in older adults in a phase 1 clinical trial, who generally tolerated it well, the National Institutes of Health reports.

The National Institute of Allergy and Infectious Diseases developed the vaccine with Moderna Inc.

The phase 1 trial began in March and later added 40 healthy adults over age 55, who received two doses and will be followed for a year to monitor the long-term effects of the vaccine. According to the researchers, the results support testing the vaccine in older adults in an ongoing large Phase 3 trial.

Novel Coronavirus (COVID-19)
COVID-19: Vaccine

Headline

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: